Talk to Simmon about these topics and more:  

• CDMO collaboration
• Inhalation drug delivery
• Transdermal drug delivery
• Life cycle management strategies

Talk to Carl about these topics and more:  

• The intersection of science and storytelling in content creation
• The role of content strategy in building life science brands
• Navigating the challenges of integrating scientific accuracy and audience engagement
• Collaborative approaches to content creation in a multidisciplinary team
• Insights into transitioning academic writing to marketing communications

Talk to Kate about these topics and more:  

• Strategies for maintaining effective communication between clients and creative teams
• Translating complex scientific concepts into compelling marketing campaigns
• The role of a strong strategic plan in enabling marketing success
• Challenges and opportunities for life science marketing
• Successful brand growth and strategic positioning

Talk to Krystle about these topics and more:  

• Developing resilient life science marketing strategies in dynamic environments
• Strategies for successful brand launches
• Key marketing, communication, and integration considerations for mergers and acquisitions
• Developing enterprise and sales enablement programs between marketing and commercial teams for success
• The role of leadership in driving cross-functional team collaboration and engagement

Talk to Cy about these topics and more:  

• Compliance with human research protection regulations and guidelines  
• IRB member therapeutic and research expertise  
• Demystifying the IRB review process  

Talk to Julie about these topics and more:  

• Human research protection regulations  
• Site operations of clinical research  
• Next-generations IRBs  

Talk to Dr. Beske about these topics and more: 

• Cell line development 
• Leap-In Transposase and Transposons 

Talk to Dr. Gustafsson about these topics and more: 

•  GPS Platform 
• Protein Engineering 
• AI Machine Learning 
• Protein Analytics 

Talk to Jay about these topics and more:

• Understanding cardiac safety requirements, including protocol design 
• Sponsor support at FDA meetings 
• Early phase development 
• Working with data and safety monitoring boards 
• Cardiac arrhythmias and electrophysiology  

Talk to Cassie about these topics and more:

• Navigating U.S. regulatory requirements, IND Submission, and Phase 1 startup and conduct 
• Efficiencies and guidance in running Phase 1 of clinical development  
• Understanding cardiac safety requirements and the best cost-saving methods 
• Developing new service programs as needs emerge 
• Rapid operational scaling/growth, strategic planning, and recapitalization